Systematic and precise interventions for KRAS-mutant cancers.
Saved in:
| Title: | Systematic and precise interventions for KRAS-mutant cancers. |
|---|---|
| Authors: | Liang J; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China., Wu J; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China., Zhang Y; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China., Wang H; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China., Zheng Y; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China., He Q; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China. heqing@nifdc.org.cn. |
| Source: | Experimental hematology & oncology [Exp Hematol Oncol] 2026 Mar 13; Vol. 15 (1). Date of Electronic Publication: 2026 Mar 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41827015 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Systematic and precise interventions for KRAS-mutant cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liang+J%22">Liang J</searchLink>; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China.<br /><searchLink fieldCode="AU" term="%22He+Q%22">He Q</searchLink>; State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing, 102629, China. heqing@nifdc.org.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101590676%22">Experimental hematology & oncology</searchLink> [Exp Hematol Oncol] 2026 Mar 13; Vol. 15 (1). <i>Date of Electronic Publication: </i>2026 Mar 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101590676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2162-3619 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221623619%22">21623619 </searchLink><i>NLM ISO Abbreviation: </i>Exp Hematol Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41827015 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40164-026-00763-7 Languages: – Code: eng Text: English Titles: – TitleFull: Systematic and precise interventions for KRAS-mutant cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liang J – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Zheng Y – PersonEntity: Name: NameFull: He Q IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 03 Text: 2026 Mar 13 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2162-3619 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Experimental hematology & oncology Type: main |
| ResultId | 1 |